Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives
Journal of Clinical Medicine · 25.12.2025 · 15 (1) · 150
DOI: 10.3390/jcm15010150 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.12.2025. Verfasst von Michał Walaszek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214 Gdańsk, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Gdansk.
Themen: Depression
Abstract (Originalsprache)
Treatment-resistant depression (TRD) remains a significant public-health challenge, with many patients failing to respond to conventional therapies. Ketamine has emerged as a rapid-acting intervention, but quantitative outcomes alone do not capture patients’ lived experiences, which shape engagement, acceptability, and adherence. We conducted a narrative review of qualitative and mixed-methods studies to enable conceptual integration and thematic synthesis of patients’ experiences with ketamine treatment for depression, guided by established narrative review methodology and the SANRA framework. A targeted search of MEDLINE and Scopus (November 2025) identified studies reporting adult patients’ perspectives on therapeutic ketamine or esketamine use, with qualitative data synthesized iteratively in keeping with narrative review principles. Across the literature, patients’ perspectives coalesce around key thematic domains, including motivations and expectations for treatment, the phenomenology of the treatment experience, post-treatment trajectories, side effects and reasons for discontinuation, relational and environmental factors, and information and education needs. By focusing on these thematic groups, the review highlights the experiential dimensions that influence the perceived value and acceptability of ketamine, underscoring the need for patient-centered service design. Integrating these insights can guide the development of ketamine programs that are both evidence-based and aligned with patients’ priorities and perspectives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214 Gdańsk, Poland.
ORCID-Profile: Michał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik
Förderung
- Medical University of Gdansk
Zitieren
APA
Walaszek, M., Cubała, W. J., & Kachlik, Z. (2025). Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives. Journal of Clinical Medicine, 15(1), 150. https://doi.org/10.3390/jcm15010150
Vancouver
Walaszek M, Cubała WJ, Kachlik Z. Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives. Journal of Clinical Medicine. 2025;15(1):150. doi:10.3390/jcm15010150
BibTeX
@article{Walaszek2025,
author = {Walaszek, Michał and Cubała, Wiesław Jerzy and Kachlik, Zofia},
title = {Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {15},
number = {1},
pages = {150},
doi = {10.3390/jcm15010150}
}
EUVIMED